Workers at pharmaceutical giant AstraZeneca are to stage a series of strikes next month in a row over pensions, it has been announced.
The GMB said members at the firm's Macclesfield site will walk out for two hours at a time throughout September 8, for four hours on September 15 and for entire eight-hour shifts from 6am on September 22 to 6am a day later, with further action planned.
The move follows a vote in favour of industrial action in protest at pension changes which the GMB described as "draconian".
The union said the firm is ending its final salary pension scheme for 2,500 staff based mainly at Macclesfield.
National officer Allan Black said the "highly profitable" pharmaceutical company is making "savage" cuts in its pension scheme.
"GMB is enormously proud of the overwhelming vote by members on this pension issue. We are also buoyed up by the messages of support from our sister unions across Europe and across the world.
"The last thing our members want to do is to take strike action at AstraZeneca but the attack by the company on the pension entitlement of our members leaves them with no choice."
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment